Transgenic modelling of neurodegenerative events gathers momentum.
Sofroniew
M V
MV
Dept of Anatomy, University of Cambridge, UK.
Staley
K
K
D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D000682:Amyloid / Q000096:biosynthesis; D016564:Amyloid beta-Protein Precursor / Q000096:biosynthesis / Q000235:genetics; D000818:Animals; D006224:Cricetinae; D004195:Disease Models, Animal; D005813:Genes, Synthetic; D016098:Gerstmann-Straussler-Scheinker Disease / Q000235:genetics / Q000473:pathology; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009410:Nerve Degeneration; D011328:Prions / Q000235:genetics; D011401:Promoter Regions, Genetic; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics; D017231:Proto-Oncogene Proteins c-mos; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012608:Scrapie / Q000235:genetics / Q000473:pathology; D013045:Species Specificity
D000682:Amyloid; D016564:Amyloid beta-Protein Precursor; D011328:Prions; D011518:Proto-Oncogene Proteins; D011993:Recombinant Fusion Proteins; D017231:Proto-Oncogene Proteins c-mos